Mealey's (June 29, 2018, 12:31 PM EDT) -- SAN FRANCISCO — A woman’s amended complaint that states she did not learn until 2016 that her 11-year use of proton pump inhibitors (PPIs) made by AstraZeneca Pharmaceuticals LP and AstraZeneca LP could have caused her to develop kidney failure that was diagnosed in 2011 sufficiently showed that the discovery rule tolled the two-year statute of limitations on her lawsuit, a Ninth Circuit U.S. Court of Appeals panel ruled June 28 in reversing a ruling dismissing the action (Cindi Bekins v. AstraZeneca Pharmaceuticals LP, et al., No. 17-55461, 9th Cir., 2018 U.S. App. LEXIS 17797)....